May 17, 2020

How are health apps supporting healthcare in India?

Technology
healthcare services
Medicine
healthcare services
Catherine Sturman
3 min
With ageing populations worldwide, the healthcare industry is having to continually develop, with new, innovative technologies and breakthroughs within...

With ageing populations worldwide, the healthcare industry is having to continually develop, with new, innovative technologies and breakthroughs within patient care and treatment. India especially has become an area of focus for the technology industry in providing increased access to services. With limited government funding and a rising demand for healthcare services which is now creating increased inequality, the country is looking at how digital apps and services can therefore support the healthcare sector and promote new and developing treatment and services.

WhatsApp and WeChat are two such apps which are integrating into the healthcare sector. With the ability for medical teams to send messages, files and patient information without being charged for the service, WhatsApp alone has amassed over one billion users worldwide. It has become the most popular app in India, with over 200 million users.

With services such as end-to-end encryption, there is decreased risk in the compromise of patient information and data breaches, and also improves communication between various clinics and teams. Doctors in India have become known to increasingly utilise these services, in addition to medical teams in countries such as China, where digital health and demand is also growing significantly.

WhatsApp has also supported the growth of other digital health companies and apps, such as 1mg. A pharmaceutical start-up company, it has received no government promotion or local government funding, yet has now been downloaded by over nine million citizens.

With the aim to “make healthcare understandable, accessible and affordable,” the company launched in 2015 and has enabled individuals to gain access to drugs through a digital database, that looks almost similar to Amazon and sources drugs at more cost-effective prices.

On their website, 1mg have stated, “buying medicines may require you to try five medical stores which are miles apart. We want you to be able to it with a click,” saving the individual time and increased costs. They add, “we want you to know about medicines which have the same composition as prescribed by your doctor but can be considerably cheaper.” The product is then delivered to the persons home, an appealing factor for those who live in rural areas, are too unwell to walk long distances or work significantly long hours.

The company has gained significant financial investment from companies such as Sequoia, Intel Capital, Kae Capital and the Omidyar Network, and has been recognised by the Government of India – Ministry of Health and Family Welfare, winning a large number of awards.

Another health app gaining ground in India is DocsApp, which gives patients the ability to source a doctor, anytime, anywhere. Users can consult doctors in less than 30 minutes through the app, with over 1000,000 patients treated since its launch. The app is perfect for those who cannot make it to a doctor, or are not able to be seen by a doctor quick enough.

With over 1500 doctors in 19 different specialities, DocsApp has become an essential app within India’s healthcare sector, and is approved by the Health Insurance Portability and Accountability Act 1996 (HIPPA). Patients can send pictures and send private messages and receive a swift response. With regards to payments, patients are able to pay through their mobile balance, making the process less time consuming and hassle free.

Share article

Jun 18, 2021

Skin Analytics wins NHSX award for AI skin cancer tool 

AI
NHS
skincancer
Cancer
2 min
Skin Analytics uses AI to detect skin cancer and will be deployed across the NHS to ease patient backlogs

An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system. 

NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion. 

Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making. 

In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog. 

Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening. 

DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.

Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.

Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges. 

"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”

Share article